Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 990 results for "us fda"

First-in-Human Use of CRISPR for Cancer Treatment Approved in the US

Pill to treat hepatitis C backed by FDA

Epclusa by Gilead Sciences Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus. The Food and ... CNBC, 3 hours ago
FDA approves first pill to treat all forms of hepatitis C, 6 hours ago

546 images for us fda

PharmaVOICE, 2 weeks ago, 6 hours ago
The Malaysian Times, 1 week ago, 4 minutes ago
Nasdaq, 10 hours ago
HCPLive, 6 hours ago
Nasdaq, 1 day ago, 17 hours ago
Pharmaceutical Journal, 3 weeks ago, 1 week ago

U.S. FDA panel backs claim Lilly diabetes drug

Eli Lilly & Co and Boehringer Ingelheim should be allowed to claim that their diabetes drug Jardiance cuts the risk of cardiovascular death, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The FDA is not obliged ...
 Reuters UK2 hours ago US FDA panel backs claim Lilly diabetes drug  Channel NewsAsia2 hours ago U.S. panel backs claim Lilly diabetes drug cuts cardiac death  HealthMediciNet.com28 minutes ago UPDATE 2-U.S. panel backs claim Lilly diabetes drug cuts cardiac death  Reuters UK1 hour ago
Motley Fool

The FDA Unsurprisingly Approves Gilead's New Hepatitis C Drug. Now What?

Image source: . Shares in Gilead Sciences ( NASDAQ:GILD ) were jumping more than 4% earlier today on word that the FDA has given the green light to its next-generation hepatitis C drug, Epclusa. The FDA's decision to approve Epclusa was widely ...
 Motley Fool25 minutes ago Instant Analysis: Gilead Sciences Wins an Important FDA Approval  Motley Fool4 hours ago Thermo Fisher Scientific Receives FDA Clearance for New Allergen Component Tests for Hazelnut, Walnut and Cashew Nut IgE Sensitization  Money Control2 months ago

Gilead's New Hepatitis C Drug Approved by FDA, Priced at $74,760

Gilead Sciences Inc.'s hepatitis C drug was approved by U.S. regulators for all forms of the viral disease, making it the first treatment with such a comprehensive label. The drug, called Epclusa, can be used by patients with any of the six ...
 Bloomberg6 hours ago FDA Approves New Combo Drug for Hepatitis C  HealthMediciNet.com28 minutes ago Gilead wins FDA nod for pan-genotypic Hep C drug  BioPharma Dive52 minutes ago FDA approves a Gilead pill that is first to treat all forms of hepatitis C  StatNews.com4 hours ago

FDA Approves Gilead's Epclusa To Treat Genotypes Of Chronic Hepatitis C

Gilead Sciences Inc. (GILD) announced that the U.S. Food and Drug Administration has approved Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg), the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 ...
 RTTNews.com8 hours ago 6/28/16 - FDA Approves Gilead's Epclusa To Treat Genotypes Of Chronic Hepatitis C  Pharmacy Choice36 minutes ago GILEAD SCIENCES : U.S. Food and Drug Administration Approves Gilead's Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C  4 Traders8 hours ago

4 Stocks Moving In Monday's After-Hours Session: FDA, Earnings, Dividends And M&A

U.S. markets closed substantially down on Monday, driven by lower oil prices, the Brexit, as well as financial and materials stocks. Let's take a look into a few stocks that continued to move in Monday's after-hours session. Ennis, Inc. (NYSE: ...
 Benzinga.com1 day ago 4 Stocks Moving In Tuesday's After-Hours Session: Earnings, Buybacks & FDA Setbacks  Fat Pitch Financials2 hours ago

FDA Approves Epclusa (sofosbuvir and velpatasvir) for Treatment of all Major Forms of Chronic Hepatitis C Virus Infection

-- The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to
 Drugs.com5 minutes ago FDA approves Epclusa for all HCV genotypes  Healio4 hours ago Epclusa drug receives FDA approval for treating adult patients with chronic HCV  News-Medical.Net5 hours ago FDA approves Epclusa for treatment of chronic Hepatitis C virus infection  BioSpace8 hours ago

FDA Advisory Committee recommends approval of Jardiance® (empagliflozin) for cardiovascular indication in 12-11 vote

/PRNewswire/ -- A U.S. Food and Drug Administration (FDA) Advisory Committee today voted 12-11 that substantial evidence exists to establish that Jardiance® (empagliflozin) reduces cardiovascular (CV) death in adults with type 2 diabetes (T2D) and ...
 Nasdaq45 minutes ago

Esperion Therapeutics Inc. (ESPR) Is Falling On FDA News

Esperion Therapeutics Inc. (ESPR) announced after the bell Tuesday that they have failed to reach an agreement with the FDA on a regulatory pathway for an LDL-C lowering indication in the U.S. on ETC-1002 in statin intolerant patients. The stock is ...
 RTTNews.com1 hour ago
Libya News Today

Regulus Shares Crumble As FDA Puts Hep C Treatment on Hold

Regulus Reports Clinical Hold Of RG-101 LA JOLLA, Calif. , June 27, 2016 /PRNewswire/ -- Regulus Therapeutics Inc . (Nasdaq: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, ...
 BioSpace9 hours ago FDA places Regulus' Hep C drug on clinical hold; shares dive  Sharenet1 day ago FDA places Regulus Hep C drug on clinical hold; shares dive  Reuters UK1 day ago FDA seeks suspension of 4,402 illegal prescription drug websites  Reuters2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less